BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33734012)

  • 1.
    Zhou J; Singh BK; Ho JP; Lim A; Bruinstroop E; Ohba K; Sinha RA; Yen PM
    Autophagy; 2021 Dec; 17(12):4043-4061. PubMed ID: 33734012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
    Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
    Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase.
    Viswakarma N; Jia Y; Bai L; Gao Q; Lin B; Zhang X; Misra P; Rana A; Jain S; Gonzalez FJ; Zhu YJ; Thimmapaya B; Reddy JK
    J Biol Chem; 2013 Sep; 288(39):27898-911. PubMed ID: 23943624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1.
    Li K; Zhao B; Wei D; Wang W; Cui Y; Qian L; Liu G
    Int J Mol Med; 2020 Feb; 45(2):543-555. PubMed ID: 31894315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease.
    Ren Q; Sun Q; Fu J
    Autophagy; 2024 Feb; 20(2):221-241. PubMed ID: 37700498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse.
    Bai L; Jia Y; Viswakarma N; Huang J; Vluggens A; Wolins NE; Jafari N; Rao MS; Borensztajn J; Yang G; Reddy JK
    Hepatology; 2011 Apr; 53(4):1164-74. PubMed ID: 21480322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy.
    Yoo J; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Metabolism; 2021 Jul; 120():154798. PubMed ID: 33984335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis.
    Jia Y; Viswakarma N; Fu T; Yu S; Rao MS; Borensztajn J; Reddy JK
    Gene Expr; 2009; 14(5):291-306. PubMed ID: 19630272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic
    Lee YH; Jang HJ; Kim S; Choi SS; Khim KW; Eom HJ; Hyun J; Shin KJ; Chae YC; Kim H; Park J; Park NH; Woo CY; Hong CH; Koh EH; Nam D; Choi JH
    Elife; 2021 Dec; 10():. PubMed ID: 34964438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming.
    Spitler KM; Ponce JM; Oudit GY; Hall DD; Grueter CE
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H768-H780. PubMed ID: 28159809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice.
    Brocker CN; Patel DP; Velenosi TJ; Kim D; Yan T; Yue J; Li G; Krausz KW; Gonzalez FJ
    J Lipid Res; 2018 Nov; 59(11):2140-2152. PubMed ID: 30158201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis.
    Misra P; Reddy JK
    Biochimie; 2014 Mar; 98():63-74. PubMed ID: 24291192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdc2-like kinase 2 suppresses hepatic fatty acid oxidation and ketogenesis through disruption of the PGC-1α and MED1 complex.
    Tabata M; Rodgers JT; Hall JA; Lee Y; Jedrychowski MP; Gygi SP; Puigserver P
    Diabetes; 2014 May; 63(5):1519-32. PubMed ID: 24458359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of hepatic autophagy by stress-sensing transcription factor CREBH.
    Kim H; Williams D; Qiu Y; Song Z; Yang Z; Kimler V; Goldberg A; Zhang R; Yang Z; Chen X; Wang L; Fang D; Lin JD; Zhang K
    FASEB J; 2019 Jul; 33(7):7896-7914. PubMed ID: 30912978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
    Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
    Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediator subunit MED1 modulates intranuclear dynamics of the thyroid hormone receptor.
    Femia MR; Evans RM; Zhang J; Sun X; Lebegue CJ; Roggero VR; Allison LA
    J Cell Biochem; 2020 Apr; 121(4):2909-2926. PubMed ID: 31692077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.
    Sun N; Shen C; Zhang L; Wu X; Yu Y; Yang X; Yang C; Zhong C; Gao Z; Miao W; Yang Z; Gao W; Hu L; Williams K; Liu C; Chang Y; Gao Y
    Gut; 2021 Nov; 70(11):2183-2195. PubMed ID: 33257471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperlipidemia in hepatic MED1 deficient mice in response to fasting].
    Bai L; Fu T; Jia Y; Borensztajn J; Reddy JK; Yang G
    Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1490-8. PubMed ID: 22260066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesis.
    Jia Y; Viswakarma N; Reddy JK
    Gene Expr; 2014; 16(2):63-75. PubMed ID: 24801167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.